Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets 857.75M
Total Liability 434.48M
Assets-to-Libability Ratio 1.97
Total Current Assets 362.80M
Total Current Liability 143.88M
Current Ratio 2.52
Quick Ratio 2.33
Debt to Equity Ratio 0.64
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

Nextgen Healthcare Inc (NXGN)

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.

Exchange: NASDAQ

IPO Date: 1/2/2001

Sector: Healthcare

Industry: Health Information Services

Employees: 2783

Address: Building 6, Atlanta, GA, United States, 30305

https://www.nextgen.com

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Assets
857.75K868.47K896.10K871.02K627.14K608.00K627.67K605.33K635.52K624.56K22.59M
Current Assets
362.80K374.73K401.82K389.64K218.15K192.54K211.57K185.74K210.71K194.19K8.47M
Cash And Short Term Investments
200.30K218.10K238.33K241.55K70.73K40.36K59.83K49.43K75.30K63.00K3.39M
Net Receivables
118.82K108.80K113.31K105.91K105.47K110.11K107.72K101.29K101.58K94.71K3.98M
Inventory
27.59K7.58K--------43.84K
Other Current Assets
16.09K40.26K42.92K34.26K13.72K12.87K12.87K35.02K33.84K36.48K919.10K
Non Current Assets
494.95K493.74K494.28K481.39K408.99K415.46K416.10K419.59K424.81K430.37K14.12M
Property Plant Equipment
-5.56K-7.23K7.40K8.33K20.44K23.86K26.46K29.92K815.59K
Long Term Investments
-----------
Non Currrent Assets Other
37.49K44.90K49.81K43.75K40.53K41.61K40.94K39.96K39.62K39.05K1.16M
Liabilities
434.48K457.95K495.67K453.26K185.30K179.14K204.60K194.19K200.25K186.00K8.66M
Current Liabilities
143.88K167.84K198.11K154.20K168.61K157.60K180.86K170.41K171.18K155.06K5.50M
Accounts Payable
10.47K12.18K12.02K14.51K12.41K15.04K9.13K15.23K12.69K7.21K973.05K
Short Long Term Debt
----------306.99K
Other Current Liabilities
76.87K103.82K120.66K72.78K80.06K71.52K102.37K86.65K87.94K78.70K3.67M
Non Current Liabilities
290.60K290.11K297.56K299.06K16.68K21.54K23.73K23.78K29.07K30.93K3.16M
Long Term Debt
-267.16K-266.59K------1.56M
Other Liabilities
----11.54K11.74K11.80K11.00K14.42K14.51K602.85K
Stockholder Equity
423.27K410.52K400.44K417.76K441.84K428.86K423.08K411.14K435.28K438.57K13.93M
Preferred Stock Equity
-----------
Liabilities And Stockholders Equity
857.75K868.47K896.10K871.02K627.14K608.00K627.67K605.33K635.52K624.56K22.59M
Common Equity
-719-70970470469269068467423.93K
Retained Earnings
-133.75K-152.84K145.02K131.40K130.25K129.90K124.71K131.48K3.69M
Totals4.35M4.87M4.66M4.88M3.18M3.05M3.21M3.11M3.26M3.18M3.20M3.39M3.51M4.28M3.93M3.25M2.97M2.95M2.79M2.79M2.83M2.90M2.75M2.65M2.76M2.57M2.51M2.43M2.55M2.76M3.04M2.38M2.39M2.44M2.58M2.44M2.45M2.45M2.47M120.16M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;03/31/202303/31/202203/31/202103/31/202003/31/201903/31/201803/31/201703/31/201603/31/201503/31/2014Totals
Assets
896.10K627.67K644.49K720.12K532.89K515.75K473.22K530.79K460.52K445.06K5.85M
Current Assets
401.82K211.57K207.64K260.01K159.85K141.66K146.80K183.99K280.06K260.36K2.25M
Cash And Short Term Investments
238.33K59.83K73.30K138.01K33.08K28.84K42.59K41.79K133.00K118.15K906.93K
Net Receivables
113.31K107.72K97.79K93.39K104.38K93.08K86.09K126.73K110.82K118.55K1.05M
Inventory
--25.96K20.33K12018015855562283448.76K
Other Current Assets
42.92K12.87K10.60K8.28K22.27K19.55K17.97K14.91K11.54K11.13K172.04K
Non Current Assets
494.28K416.10K436.84K460.10K373.04K374.09K326.42K346.80K180.46K184.70K3.59M
Property Plant Equipment
-20.44K32.98K19.84K21.40K26.80K27.43K25.79K20.81K22.80K218.28K
Long Term Investments
-----------
Non Currrent Assets Other
49.81K40.94K37.02K33.66K36.23K18.80K19.01K19.05K18.00K16.93K289.43K
Liabilities
495.67K204.60K212.84K319.62K156.95K192.34K168.18K261.41K176.98K149.97K2.34M
Current Liabilities
198.11K180.86K180.63K143.22K128.23K134.59K128.69K138.06K155.08K123.89K1.51M
Accounts Payable
12.02K9.13K11.38K10.52K5.43K4.21K29.54K29.89K54.82K34.53K201.46K
Short Long Term Debt
----78267215.00K105.00K--121.45K
Other Current Liabilities
120.66K102.37K103.66K65.29K62.80K72.01K99.16K108.17K100.27K89.36K923.75K
Non Current Liabilities
297.56K23.73K32.21K176.40K28.72K57.75K39.48K123.35K21.90K26.08K827.19K
Long Term Debt
---129.00K11.00K37.00K15.00K105.00K--297.00K
Other Liabilities
-11.80K13.76K8.58K17.72K20.75K24.48K18.35K21.90K26.08K163.42K
Stockholder Equity
400.44K423.08K431.64K400.49K375.95K323.41K305.04K269.38K283.54K295.09K3.51M
Preferred Stock Equity
-----------
Liabilities And Stockholders Equity
896.10K627.67K644.49K720.12K532.89K515.75K473.22K530.79K460.52K445.06K5.85M
Common Equity
-6926716616486406256106036025.75K
Retained Earnings
-130.25K-119.12K111.62K78.71K76.23K57.99K84.48K99.93K758.32K
Totals4.66M3.21M3.20M3.85M2.72M2.66M2.51M3.04M2.58M2.47M30.88M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;06/30/202203/31/202212/31/202109/30/202106/30/202103/31/202112/31/202009/30/202006/30/202003/31/2020Totals
Revenue
153.30K151.26K149.72K149.29K146.08K144.19K141.75K140.00K130.88K136.38K4.51M
Cost Of Revenue
80.05K75.76K74.20K72.70K72.74K69.78K70.32K68.95K66.37K68.34K2.13M
Gross Profit
73.25K75.50K75.52K76.59K73.34K74.41K71.43K71.05K64.51K68.04K2.38M
Operating Expenses
71.53K70.36K67.51K83.29K68.69K71.37K68.28K60.75K60.07K66.04K2.17M
Selling General Administrative
49.03K50.05K47.24K63.89K48.49K48.87K48.97K41.95K40.74K43.16K1.48M
Research Development
21.80K19.43K19.39K18.52K19.32K21.39K18.20K17.69K18.22K21.43K647.86K
Other Operating Expenses
151.59K146.12K141.71K155.99K141.43K141.15K138.60K129.70K126.44K134.38K4.30M
Operating Income
1.19K2.81K8.01K-7.90K3.73K-5.07K3.15K10.30K4.44K2.01K196.87K
Net Interest Income
-284-519-271-303-305-632-622-1.12K-1.10K-550-7.35K
Interest Income
4622501712119126111-51
Interest Expense
3305413213203176436311.14K1.11K66117.73K
Other Income Expense Net
-289-540-280-315-3274.10K2.85K1.14K3.65K8.21K80.18K
Income Before Tax
9012.27K7.73K-8.21K3.41K-9692959.16K792-6.21K121.38K
Tax Provision
-2471.93K2.54K-1.44K559-389-169-1.30K1.62K-1.97K2.10K
NetIncome
1.15K3485.19K-6.77K2.85K-58046410.46K-824-4.24K103.12K
NetIncome Applicable To Common Shares
1.15K3485.19K-6.77K2.85K-58046410.46K-824-4.24K103.12K
Ebit
1.23K2.81K8.05K-7.89K3.72K-32692610.29K1.90K-5.55K139.27K
Basic EPS
-0.190.240.290.250.210.260.30.210.26.630000000000002
Totals605.73K598.49K611.82K580.99K586.91K567.37K565.56K580.63K517.99K526.00K556.63K549.85K527.99K557.39K540.61K555.48K547.56K527.97K537.01K560.44K542.68K554.48K549.43K529.24K490.58K454.80K491.25K529.33K510.64K550.68K520.85K497.68K486.50K478.93K18.39M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;03/31/202203/31/202103/31/202003/31/201903/31/201803/31/201703/31/201603/31/201503/31/2014Totals
Revenue
596.35K556.82K540.24K529.17K531.02K509.62K492.48K490.23K444.67K4.69M
Cost Of Revenue
295.40K275.42K267.44K246.70K241.53K223.13K225.62K223.16K220.16K2.22M
Gross Profit
300.95K281.40K272.80K282.48K289.48K286.49K266.86K267.06K224.50K2.47M
Operating Expenses
289.84K260.48K252.61K250.22K282.30K252.40K227.26K231.10K195.54K2.24M
Selling General Administrative
209.66K180.53K165.17K164.88K193.23K163.62K156.23K158.17K149.21K1.54M
Research Development
76.66K75.50K83.30K80.99K81.26K78.34K65.66K69.24K41.52K652.47K
Other Operating Expenses
585.25K535.90K520.05K496.91K523.83K475.53K452.88K454.27K415.71K4.46M
Operating Income
6.66K12.82K5.11K31.62K2.82K34.09K39.60K35.96K28.96K197.63K
Net Interest Income
-1.40K-3.48K-1.70K-2.60K-3.27K-3.14K----15.58K
Interest Income
101382562165514-876---196
Interest Expense
1.50K3.52K1.96K2.81K3.32K3.16K1.30K230-17.80K
Other Income Expense Net
-1.46K-3.54K-853-2.33K-3.23K10.48K33.28K2925.96K38.59K
Income Before Tax
5.20K9.28K4.26K29.29K-41023.61K6.32K35.66K23.00K136.20K
Tax Provision
3.58K-240-3.24K4.79K-2.83K5.37K6638.33K-16.43K
NetIncome
1.62K9.52K7.50K24.49K2.42K18.24K5.66K27.33K15.68K112.45K
NetIncome Applicable To Common Shares
1.62K9.52K7.50K24.49K2.42K18.24K5.66K27.33K15.68K112.45K
Ebit
6.70K12.79K6.21K32.10K2.91K26.77K7.62K35.66K23.00K153.77K
Basic EPS
0.970.980.830.860.70.820.720.630.737.24
Totals2.38M2.22M2.13M2.20M2.15M2.13M1.99M2.06M1.80M19.05M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;09/30/202306/30/202303/31/202312/31/202209/30/202206/30/202203/31/202212/31/202109/30/202106/30/2021Totals
Cash From Operating Activities
-9.42K-8.10K7.68K2.18K38.44K-4.64K16.91K16.16K20.17K313658.69K
Net Income
5.05K6.16K-25.24K7.82K13.62K1.15K3485.19K-6.77K2.85K110.53K
Depreciation
9.31K9.30K9.86K8.90K8.80K9.13K10.02K10.70K10.52K11.07K384.74K
Extraordinary Items
-----------
Change Receivables
-3.50K-9.75K-1.10K-63-1.46K-6.75K1.45K1.47K3.41K22.57K
Change To Inventory
5.37K-2.75K--------2.89K
Change To Liabilities
--11.29K8.63K-5.32K3.69K-17.03K4803.86K6.67K-4.92K205
Change To Net Income
-9.82K2.50K10.74K9.69K9.53K12.26K9.09K8.77K8.95K240.73K
ChangeToOperatingActivities
----14.12K-31.00K-310-12.63K9.30K-20.72K-38.11K
Cash flows From Investing Activities
--16.69K-151.73K-56.57K864-9.45K-8.21K-6.48K-6.86K-6.54K-731.99K
Capital Expenditures
-9.60K-8.68K-8.30K-9.12K-10.39K-9.45K-8.21K-6.48K-6.86K-6.54K-265.62K
Other Cashflows From Investing Activities
-12.54K-11.93K-55.94K1.83K-9.00K-7.66K-6.12K-6.17K-5.54K-202.78K
Cash From Financing Activities
-2.43K-3.25K566225.48K-9.32K-4.11K3.70K-36.90K-1.79K-2.30K55.09K
Net Borrowings
---266.52K------365.03K
Sale Purchase Of Stock
-6501.44K-40.00K-7.37K-2.50K4.14K-35.87K438671-58.90K
Dividends Paid
-----------96.31K
Other Cashflows From Financing Activities
-2.43K-3.25K50.57K315.48K-1.95K-1.60K3.70K-1.02K-1.79K-2.30K705.15K
Cash And Cash Equivalents Changes
--28.03K-143.48K171.09K29.98K-18.20K12.40K-27.21K11.51K-8.53K8.79K
Totals-4.13K-40.07K-269.19K840.16K91.95K-88.64K32.80K-86.27K38.60K-30.11K-32.67K-43.20K-268.55K229.10K416.21K-18.01K39.46K-8.02K-11.56K-4.85K23.69K16.78K14.74K-9.50K28.33K-17.81K46.04K-4.47K-7.79K-18.76K87.01K-23.42K-22.88K-46.45K165.88K-3.61K17.56K3.24K129.10K1.16M
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;03/31/202303/31/202203/31/202103/31/202003/31/201903/31/201803/31/201703/31/201603/31/201503/31/2014Totals
Cash From Operating Activities
43.66K53.55K98.52K85.60K50.48K76.59K110.59K40.80K82.76K104.14K746.67K
Net Income
-2.65K1.62K9.52K7.50K24.49K2.42K18.24K5.66K27.33K15.68K109.80K
Depreciation
36.69K42.31K49.21K47.79K43.13K40.40K40.43K29.74K29.27K28.74K387.72K
Extraordinary Items
-----------
Change Receivables
--431-4.94K-6.18K-5.41K5.54K9.93K4.74K40.55K53.67K
Change To Inventory
----8.23K70-73-2117187-81-8.13K
Change To Liabilities
-6.09K-3.31K3.37K2.13K-6.69K27.89K-56.43K27.02K-1.84K-1.77K
Change To Net Income
-39.07K28.46K34.12K22.76K22.28K16.24K51.31K-6.74K26.95K234.46K
ChangeToOperatingActivities
--24.36K18.29K-19.84K-34.68K21.16K1.63K-6.69K13.10K--31.39K
Cash flows From Investing Activities
--28.08K-28.55K-96.07K-25.52K-91.53K-11.40K-190.37K-24.52K-63.75K-559.81K
Capital Expenditures
-37.26K-28.08K-28.34K-26.88K-25.52K-28.67K-20.41K-28.69K-21.13K-28.72K-273.71K
Other Cashflows From Investing Activities
--25.50K-206-88.62K-20.57K-81.73K-8.53K14.68K14.60K20.78K-175.10K
Cash From Financing Activities
212.62K-37.29K-131.72K116.27K-21.65K6.12K-88.69K57.76K-42.39K-43.24K27.79K
Net Borrowings
---129.00K118.00K-26.00K20.89K-90.00K99.62K105.00K-98.51K
Sale Purchase Of Stock
-49.88K-35.87K-2.41K7.53K4.89K1.31K9923832.20K-66.04K
Dividends Paid
--------42.85K-42.77K-42.20K-127.82K
Other Cashflows From Financing Activities
312.50K-1.42K47.28K135.27K30.35K34.12K1.31K169.12K383-1.04K727.88K
Cash And Cash Equivalents Changes
--11.83K-105.80K3.30K-8.83K10.50K-91.82K15.85K-2.85K20.12K
Totals515.68K-50.23K-69.84K421.41K24.12K5.95K14.63K62.77K183.07K55.31K1.16M